9. January 2015

FDA Approves Roche's Blood Screening Assay for Simultaneous Detection and Identification of Three Major Viral Targets

Roche announced today that the FDA has approved the cobasĀ® TaqScreen MPX Test, v2.0 for use in the detection and identification of HIV, HCV, and HBV in donations of human whole blood and blood components including source plasma.

>more

Learn about the role of HPV in cervical cancer
 
What's New

30. July 2015

Roche submits filing to FDA for companion diagnostic for non-small cell lung cancer drug therapy

The cobasĀ® EGFR Mutation Test v2 is designed for expanded EGFR mutation detection in non-small cell lung cancer patients.

>more

19. July 2015

Roche expands HIV Global Access Program to include infants in resource limited settings

Program adds early infant testing to further support the 90:90:90 UNAIDS goal.

>more

18. June 2015

Roche to provide HIV diagnostic solutions to Global Fund

Framework agreement with Global Fund strengthens access to HIV diagnostics.

>more

9. June 2015

Roche to develop companion diagnostic test for acute coronary syndrome

Agreement with DalCor includes use of the assay for a phase III clinical trial of dalcetrapib.

>more

 Diagnostic and Blood Screening Tests

 

Roche Molecular Diagnostics (RMD) offers a uniquely broad range of diagnostic and blood screening assays based on the company's Nobel prize-winning PCR technologies.

 

RMD's tests and automated platforms are focused in the areas of virology, blood screening, HPV, genomics and oncology, microbiology and sexually transmitted infections. > more

 Contact

Contact your local sales representative for detailed information, questions and ordering.

 

 

 Browse Our Products

 Related Links